Patent details

Basic Information

Publication number:

EP3202392

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161806872

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ORAL DOSAGE FORMS COMPRISING LICARBAZEPINE ACETATE

French Title of Invention:

FORMES GALÉNIQUES ORALES RENFERMANT DE L'ACÉTATE DE LICARBAZÉPINE

German Title of Invention:

ORALE DOSIERFORMEN MIT LICARBAZEPIN-ACETAT

SPC Number:

Dates

Filing date:

24/10/2008

Grant date:

25/08/2021

EP Publication Date:

09/08/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/08/2021

EP B1 Publication Date:

25/08/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/10/2021

Expiration date:

24/10/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/08/2021

 

 

Name:

BIAL - Portela & Ca., S.A.

Address:

À Av. da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Portugal (PT)

Inventor

1

Name:

VASCONCELOS, Téofilo Cardoso de

Address:

Portugal (PT)

2

Name:

SANTOS LIMA, Ricardo Jorge dos

Address:

Portugal (PT)

3

Name:

CAMPOS COSTA, Rui Cerdeira

Address:

Portugal (PT)

Priority

Priority Number:

982790 P

Priority Date:

26/10/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 9/20; A61K 9/16; A61K 31/55;

Publication

European Patent Bulletin

Issue number:

202134

Publication date:

25/08/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages